Latest Natalizumab Stories

2009-05-18 15:44:31

The 57-year-old lawyer in New York had handily completed the New York Times' Saturday crossword puzzle – the hardest of the week – for years. But one Saturday morning, suddenly he couldn't retrieve the words to fill in the squares.

2009-05-15 06:00:00

Cimzia(R) (certolizumab pegol) now offered in an innovative prefilled syringe designed in partnership with OXO GOOD GRIPS(R) ATLANTA, May 15 /PRNewswire/ --- UCB today announced that Cimzia(R) (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor) approved in the U.S.

2009-05-13 21:48:00

- Available this week, Cimzia(R) (certolizumab pegol), the only pegylated anti-TNF, offers a new treatment option for U.S.

2009-03-03 10:36:40

Multiple sclerosis patients may benefit from the drug fampridine.

2009-02-18 14:46:00

Aurora St. Luke's Medical Center Discovers Way to Fight Rare, but Deadly, Side Effect from Drug. MILWAUKEE, Feb. 18 /PRNewswire/ -- Researchers at Aurora St.

2009-02-04 07:00:00

Tysabri is Decision Resources' Gold Standard Through 2017 for Relapsing-Remitting Multiple Sclerosis, According to a New Report from Decision Resources WALTHAM, Mass., Feb.

2008-12-15 14:42:08

On Monday, Biogen Idec Inc said it notified regulators of a new case of a potentially deadly brain disease in a patient being treated with its Tysabri multiple sclerosis drug, the fourth such case reported globally this year.

2008-12-01 07:00:00

Increased Uptake of Current Agents and Emergence of New Therapies Will Drive Robust Annual Market Growth, According to a New Report from Decision Resources WALTHAM, Mass., Dec.

2008-11-24 11:40:00

On Monday Italian researchers said a faulty immune reaction may be responsible for the development of epilepsy.

Word of the Day
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.